Diagnósticos da América S.A. (BVMF:DASA3)

Market Cap	3.40B +54.6%
Revenue (ttm)	9.57B -38.0%
Net Income	-1.04B
EPS	-0.83
Shares Out	1.25B
PE Ratio	n/a
Forward PE	12.80
Dividend	n/a
Ex-Dividend Date	n/a

Volume	871,300
Open	2.700
Previous Close	2.660
Day's Range	2.700 - 2.780
52-Week Range	1.180 - 4.770
Beta	0.33
Analysts	Hold
Price Target	4.16 (+52.94%)
Earnings Date	May 12, 2026

About Diagnósticos da América

Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. The company operates through Hospitals and Oncology; Diagnostics - National Operations; and Diagnostics - International Operations segments. It also offers medical, property and vehicle rental, consultancy, and franchise contracting services. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 2000. Diagnósticos da América S.A. was f...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1961
• Employees: 26,255
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: DASA3

Financial Performance

In 2025, Diagnósticos da América's revenue was 11.17 billion, a decrease of -27.10% compared to the previous year's 15.32 billion. Losses were -1.15 billion, -3.92% less than in 2024.

Analyst Summary

According to 10 analysts, the average rating for DASA3 stock is "Hold." The 12-month stock price target is R$4.16, which is an increase of 52.94% from the latest price.

Price Target

R$4.16

(52.94% upside)

Analyst Consensus: Hold